Nosocomial and antibiotic-associated diarrhoea caused by organisms other than Clostridium difficile

https://doi.org/10.1016/S0924-8579(09)70015-9Get rights and content

Abstract

Most cases of nosocomial and antibiotic-associated diarrhoea are caused by alteration of the physiological gut microflora. This alteration leads to reduced microbial metabolism of carbohydrates and primary bile acids, resulting in osmotic or secretory forms of diarrhoea. Moreover, facultative enteropathogens may experience a growth advantage due to the antibiotic-induced microflora alteration that, in turn, can harm the gut mucosa by the toxins they produce. Clostridium difficile is the major infectious agent leading to pseudomembranous colitis. However, there is increasing evidence that certain other pathogens such as enterotoxin-producing Clostridium perfringens, Staphylococcus aureus and Klebsiella oxytoca can induce mucosal deterioration and diarrhoea after antibiotic use. But, as with C. difficile, these facultative enteropathogens can also be found in the healthy population. Their contribution to disease is, therefore, controversial and their presence in the stools of antibiotic-associated diarrhoea patients is often claimed to be mere colonisation. In this respect, the causal relationship of each suspected pathogen with the development of intestinal disease has to be proved clinically and experimentally.

References (49)

  • RC Spencer

    Clinical impact and associated costs of Clostridium difficile-associated disease

    J Antimicrob Chemother

    (1998)
  • SG Sparks et al.

    Genotyping of entero-toxigenic Clostridium perfringens fecal isolates associated with antibiotic-associated diarrhea and food poisoning in North America

    J Clin Microbiol

    (2001)
  • JI Rood et al.

    Molecular genetics and pathogenesis of Clostridium perfringens

    Microbiol Rev

    (1991)
  • E Dittmar et al.

    Necrotizing enterocolitis of the neonate with Clostridium perfringens: diagnosis, clinical course, and role of alpha toxin

    Eur J Pediatr

    (2008)
  • SP Boriello et al.

    Treatment of Clostridium perfringens enterotoxin-associated diarrhoea with metronidazole

    J Infect Dis

    (1985)
  • NJ Asha et al.

    Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus

    J Clin Microbiol

    (2006)
  • G Ackermann et al.

    Prevalence and characteristics of bacteria and host factors in an outbreak situation of antibiotic-associated diarrhoea

    J Med Microbiol

    (2005)
  • MM Heimesaat et al.

    Prevalence of Clostridium difficile toxins A and B and Clostridium perfringens enterotoxin A in stool samples of patients with antibiotic-associated diarrhea

    Infection

    (2005)
  • C Abrahao et al.

    Similar frequency of detection of Clostridium perfringens enterotoxin and Clostridium difficile toxins in patients with antibiotic-associated diarrhea

    Eur J Clin Microbiol Infect Dis

    (2001)
  • T Yamagishi et al.

    Persistent high numbers of Clostridium perfringens in the intestines of Japanese aged adults

    Jpn J Microbiol

    (1976)
  • MF Stringer et al.

    Faecal carriage of Clostridium perfringens

    J Hyg (Lond)

    (1985)
  • CE Loy

    Antibiotic-associated diarrhoea: an overlooked aetiology?

    Br J Biomed Sci

    (2005)
  • N Camacho et al.

    Isolates of Clostridium perfringens recovered from Costa Rican patients with antibiotic-associated diarrhoea are mostly enterotoxin-negative and susceptible to first-choice antimicrobials

    J Med Microbiol

    (2008)
  • JM Boyce et al.

    Nosocomial antibiotic-associated diarrhea associated with enterotoxin-producing strains of meticillin-resistant Staphylococcus aureus

    Am J Gastroenterol

    (2005)
  • Cited by (65)

    • Fecal Gram staining of phagocytosed bacteria to differentiate methicillin-resistant Staphylococcus aureus: A case report

      2020, Journal of Infection and Chemotherapy
      Citation Excerpt :

      Antibiotic-associated diarrhea is a relatively common problem among hospitalized patients receiving antibiotics. The main bacterial cause is Clostridioides difficile along with other bacteria including Staphylococcus aureus, Klebsiella oxytoca [1], Salmonella spp., C. perfringens, and others [2]. S. aureus was first reported to cause antibiotic-associated diarrhea in 1954 [3].

    • Prevalence of Clostridium perfringens toxin in patients suspected of having antibiotic-associated diarrhea

      2017, Anaerobe
      Citation Excerpt :

      C. perfringens is a part of the gut flora in healthy humans; however, colonizing and overgrown C. perfringens can cause severe AAD if allowed a longer period of growth [9]. Like C. difficile, enterotoxin-producing C. perfringens causes AAD and necrotizing enterocolitis, and there is one report calling it responsible for as many as 15% of AAD cases [10]. In other reports, the prevalence of C. perfringens toxin found using the Seeplex Diarreha kit has been reported as 10.2% by Onori et al. [11] and 5.2% by Lee et al. [5] among cases of presumptive acute infectious diarrhea.

    View all citing articles on Scopus
    View full text